Dustin Brown
Optometrist · State College, PANPI 1245681881
Payments from drug & device makers
Across 79 payments — averaging $26.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$654
- Bausch & Lomb Americas Inc.$331
- Bausch & Lomb, A Division Of Bausch Health US, LLC$200
- Alcon$143
- Sun Pharmaceutical Industries Inc.$124
- Biotissue Holdings Inc.$104
- plus $550 from 12 others
What the payments were for
- Speaking & faculty fees$28113%
- Food & beverage$1,82487%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 14 | $654 |
| Bausch & Lomb Americas Inc. | 11 | $331 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $200 |
| Alcon | 3 | $143 |
| Sun Pharmaceutical Industries Inc. | 8 | $124 |
| Biotissue Holdings Inc. | 8 | $104 |
| Oyster Point Pharma, Inc. | 1 | $99 |
| Johnson & Johnson Vision Care, Inc. | 4 | $73 |
| AbbVie(2 entities) | 3 | $71 |
| Maculogix, Inc. | 1 | $66 |
| Novartis | 3 | $58 |
| Tarsus Pharmaceuticals, Inc. | 2 | $46 |
| Shire North American Group Inc | 3 | $45 |
| Kala Pharmaceuticals, Inc. | 2 | $34 |
| Thea Pharma Inc. | 1 | $22 |
| Dompe US, Inc. | 1 | $16 |
| Topcon Healthcare, Inc. | 1 | $14 |
| Quidel Corporation | 1 | $6 |
How this compares
$2,105 in reported general payments places this provider in the 75th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 24 | $19,816 |
| Travoprost | 12 | $3,598 |
| Latanoprost | 115 | $2,038 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 89 | $1,939 |
| Prednisolone Acetate | 40 | $1,157 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $400 |
| Brimonidine Tartrate | 15 | $341 |
| Doxycycline Hyclate | 17 | $285 |
| ErythromycinErythromycin Base | 24 | $238 |
| Timolol Maleate | 13 | $151 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Other optometrist in State College
- Michael CymborState College$158K
- Michael TaloneState College$14K
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Glenn CorbinWyomissing$426K
- Leslie O DellNew Freedom$409K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$267K
- Erick HendersonPittsburgh$266K
- Natasha HindmanCranberry Twp$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.